Robert Allen
Hoofd Techniek/Wetenschap/O&O bij INVIVYD, INC.
Vermogen: - $ op 31-05-2024
Actieve functies van Robert Allen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INVIVYD, INC. | Hoofd Techniek/Wetenschap/O&O | 12-04-2023 | - |
Loopbaan van Robert Allen
Eerdere bekende functies van Robert Allen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
SmartPharm Therapeutics, Inc.
 SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 | 01-01-2023 |
| Oregon Translational Research & Development Institute | Hoofd Techniek/Wetenschap/O&O | - | - |
| SORRENTO THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Robert Allen
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Georgia Institute of Technology | Graduate Degree |
| Rhodes College | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
Operationeel
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Oregon Translational Research & Development Institute | |
SmartPharm Therapeutics, Inc.
SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Robert Allen
- Ervaring
